Intellectual Property FDA Hurts Patients By Authorizing Florida’s Drug Importation Program Christina Smith January 12, 2024 Misguided Use of March-In Rights Will Harm Patients Christina Smith December 6, 2023 Biden Price Controls Kill Innovation and Patients Christina Smith October 6, 2023 Biden’s Budget and the SMART Prices Act Will Devastate Drug Development Thomas Schatz June 24, 2023 Recognizing Women’s Medical Innovations on World IP Day Christina Smith April 26, 2023 Celebrating Creative Women on World IP Day Deborah Collier April 26, 2023 « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Next » ANTITRUST ARTIFICIAL INTELLIGENCE BIOPHARMACEUTICALS INTELLECTUAL PROPERTY PRIVACY TECHNOLOGY AND INNOVATION TELECOMMUNICATIONS ANTITRUST ARTIFICIAL INTELLIGENCE BIOPHARMACEUTICALS INTELLECTUAL PROPERTY PRIVACY TECHNOLOGY AND INNOVATION TELECOMMUNICATIONS Email
FDA Hurts Patients By Authorizing Florida’s Drug Importation Program Christina Smith January 12, 2024
